Cadence Pharmaceuticals' CEO Ted Schroeder to Present at Three … - Forbes
April 30th, 2008SAN DIEGO, April 30 /PRNewswire-FirstCall/ — Cadence Pharmaceuticals, Inc. (Nasdaq: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting …